SCM
MDT icon

Steadfast Capital Management’s Medtronic MDT Stock Holding History

Steadfast Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-187,000
Closed -$17.8M – 153
2025
Q3 		$17.8M Buy
+187,000
New +$17.2M 0.31% 55
2020
Q3 		– Sell
-1,455,952
Closed -$134M – 97
2020
Q2 		$134M Buy
+1,455,952
New +$140M 1.53% 24

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Steadfast Capital Management's MDT Position: Q4 2025 in Review

Steadfast Capital Management sold out of Medtronic (MDT) in Q4 2025, closing a stake of 187,000 shares — an estimated $17.8M sold.

Steadfast Capital Management first reported a position in MDT in Q2 2020 and held it in 2 quarters. The position peaked at $134M in Q2 2020. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Steadfast Capital Management reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Steadfast Capital Management sold 187,000 Medtronic shares in Q4 2025, an estimated $17.8M.
  • Steadfast Capital Management first reported a position in Medtronic in Q2 2020 and held it in 2 quarters.
  • Steadfast Capital Management's Medtronic position peaked at $134M in Q2 2020.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Steadfast Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.